The week in charts: Pharma tariffs, core sectors reset, rural income

IN · 2026-07-25

1. Step 1 · The triggerIndian generic medicines enter the US duty-free for two years.
2. Step 2 · Knock-onAfter two years, a 100% tariff is imposed, increasing costs for Indian firms.
3. Step 3 · Knock-onTariff doubles to 200%, severely limiting Indian firms' market access.
4. Step 4 · Reaches youUS pharmaceutical companies benefit from reduced competition, potentially increasing their market share.

The trigger is reported by the source below. The steps that follow are Branch²’s traced reasoning — how the shock could reach a business like yours, not a prediction.

Source: LiveMint — Economy

This is automated analysis for information only. It is not investment advice, not a recommendation, and not a solicitation to buy or sell any security. Branch² is not authorised or regulated. Do your own research.